Edaravone 98%
| Price | Get Latest Price | ||||
| Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-16
Product Details
- Product NameEdaravone
- CAS No.89-25-8 / 19735-89-8
- EINECS No.201-891-0
- MFC10H10N2O
- MW174.2
- InChIKeyQELUYTUMUWHWMC-UHFFFAOYSA-N
- AppearanceCrystalline PowderYellow to beige
- Boiling point 287 °C265 mm Hg(lit.)
- Melting point 126-128 °C(lit.)
- density 1,12 g/cm3
- Water Solubility 3 g/L (20 ºC)
- storage temp. 2-8°C
Company Profile Introduction
Aruvi Labs is a 3 years 7 months old Proprietorship Firm incorporated on 03-Mar-2021, having its registered office located at 748/16, Ground Floor, Korattur, 28Th Street Tnhb Colony, Chennai, Tamil Nadu.
The major activity of Aruvi Labs is Services, Sub-classified into Scientific research and development and is primarily engaged in the Research and experimental development on natural sciences and engineering.
Aruvi Labs is classified as Micro enterprise in the financial year 2020-21. It has its unit situated at Chennai, Tamil Nadu.
Supplier other products
Recommended supplier
-
VIP1年
- Symed Laboratories Ltd
- 89-25-8 / 19735-89-8 98%
- Inquiry
- 2024-03-21
-
VIP1年
- Vijaya Pharma And Life Science
- Edaravone 98%
- Inquiry
- 2024-03-13
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- Edaravone 89-25-8 / 19735-89-8 98%
- Inquiry
- 2024-02-24
-
VIP1年
- Biophore India Pharmaceuticals Pvt Ltd
- Edaravone 98%
- Inquiry
- 2024-02-21
-
VIP1年
- Sumar Biotech LLP
- 89-25-8 / 19735-89-8 98%
- Inquiry
- 2024-02-19
-
VIP1年
- Prima Chemicals
- 89-25-8 / 19735-89-8 Edaravone 98%
- Inquiry
- 2024-02-16
-
VIP1年
- Jayvir Dye Chem
- Edaravone 89-25-8 / 19735-89-8 98%
- Inquiry
- 2024-02-15
-
VIP1年
- PROTECH TELELINKS
- Edaravone 98%
- Inquiry
- 2024-02-09
-
VIP1年
- Gland Pharma Ltd
- 89-25-8 / 19735-89-8 98%
- Inquiry
- 2024-02-08
-
VIP1年
- Ralington Pharma
- 89-25-8 / 19735-89-8 Edaravone 98%
- Inquiry
- 2024-02-05
- Since:2020-01-01
- Address: No.76A/1, SIDCO Industrial estate , 11th Street, Ambattur, Chennai, Tamil Nadu-600098, India.
INQUIRY